Clinical trial

Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse…

NCT00309192 · Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA, Other · Completed

Key facts

NCT number NCT00309192
Title Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema
Official title Efficacy and Safety of Intravitreal Triamcinolone as Treatment of the Diffuse Diabetic Macular Edema
Lead sponsor Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA, Other
Collaborators Fondo de Investigacion Sanitaria
Status Completed
Phase Phase 3
Study type Interventional
Conditions Diabetes Mellitus, Macular Edema
Intervention type Drug, Procedure
Interventions Triamcinolone Acetonide, Grid laser, Sham Injection
Enrollment 292
Start date Apr 1, 2006
Primary completion Jul 1, 2009
Completion Jul 1, 2009
First posted Mar 31, 2006
Last update posted Mar 14, 2023
Countries Spain

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies